Dysfunction and infection of freshly isolated blood myeloid and plasmacytoid dendritic cells in patients infected with HIV-1

Blood

Volumn 101, Issue 11, 2003, Pages 4505-4511

  Donaghy, Heather ^b   Gazzard, Brian ^b   Gotch, Frances ^b   Patterson, Steven ^a  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CELL POPULATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MIXED LYMPHOCYTE REACTION; PRIORITY JOURNAL; PROVIRUS; T LYMPHOCYTE; BLOOD CELL; BONE MARROW CELL; CELL COUNT; IMMUNITY; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MIXED LYMPHOCYTE CULTURE; PATHOLOGY; VIROLOGY;

BLOOD CELLS; CELL COUNT; DENDRITIC CELLS; HIV INFECTIONS; HIV-1; HUMANS; IMMUNITY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE CULTURE TEST, MIXED; MALE; MYELOID CELLS; T-LYMPHOCYTES;

EID: 0038142359     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-10-3189     Document Type: Article

References (42)

1. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature. 1998;392:245-248.
2. Hart DN. Dendritic cells: unique leukocyte populations which control the primary immune response. Blood. 1997;90:3245-3287.
3. Rissoan MC, Soumelis V, Kadowaki N, et al. Reciprocal control of T helper cell and dendritic cell differentiation. Science. 1999;283:1183-1186.
4. Robinson SP, Patterson S, English NE, Davies D, Knight SC, Reid CDL. Human peripheral blood contains two distinct lineages of dendritic cells. Eur J Immunol. 1999;29:2769-2778.
5. + subset of human blood dendritic cells is a direct precursor of Langerhans cells. J Immunol. 1999;163:1409-1419.
6. Siegal FP, Kadowaki N, Shodell M, et al. The nature of the principal type 1 interferon-producing cells in human blood. Science. 1999;284:1835-1837.
7. Cella M, Jarrossay D, Facchetti F, et al. Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon. Nat Med. 1999;5:919-923.
8. Bacaregen L, Heinzinger N, Stevenson M, Gendelman HE. Alpha-interferon-induced antiretroviral activities: restriction of viral nucleic-acid synthesis and progeny virion production in human immunodeficiency virus type 1 infected monocytes. J Virol. 1994;68:7559-7565.
9. Facchetti F, De Wolf-Peeters C, van den Oord JJ, De vos R, Desmet VJ. Plasmacytoid T cells: a cell population normally present in the reactive lymph node: an immunohistochemical and electronmicroscopic study. Hum Pathol. 1988;19:1085-1092.
10. Grouard G, Rissoan MC, Filgueira L, et al. The enigmatic plasmacytoid T cells develop into dendritic cells with interleukin (IL)-3 and CD40-ligand. J Exp Med. 1997;185:1101-1111.
11. Carmichael A, Jin X, Sissons P, Borysiewicz L. Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease. J Exp Med. 1993;177:249-256.
12. Donaghy H, Pozniak A, Gazzard B, et al. Loss of blood CD11c(+) myeloid and CD11c(-) plasmacytoid dendritic cells in patients with HIV-1 infection correlates with HIV-1 RNA virus load. Blood. 2001;98:2574-2576.
13. Grassi F, Hosmalin A, McIlroy D, Calvez V, Debre P, Autran B. Depletion in blood CD11c-positive dendritic cells from HIV-infected patients. AIDS. 1999;13:759-766.
14. Jones GJ, Watera C, Patterson S, et al. Comparative loss and maturation of peripheral blood dendritic cell subpopulations in African and non-African HIV-1-infected patients. AIDS. 2001;15:1657-1663.
15. Pacanowski J, Kahi S, Baillet M, et al. Reduced blood CD123(+) (lymphoid) and CD11c(+) (myeloid) dendritic cell numbers in primary HIV-1 infection. Blood. 2001;98:3016-3021.
16. Patterson S, Knight SC. Susceptibility of human peripheral blood dendritic cells to infection by human immunodeficiency virus. J Gen Virol. 1987;68:1177-1181.
17. Langhoff E, Terwilliger EF, Bos HJ, et al. Replication of human immunodeficiency virus type 1 in primary dendritic cells. Proc Natl Acad Sci U S A. 1991;88:7998-8002.
18. Macatonia SE, Lau R, Patterson S, Pinching AJ, Knight SC. Dendritic cell infection, depletion and dysfunction in HIV-infected individuals. Immunology. 1990;71:38-45.
19. Patterson S, English NR, Longhurst H, et al. Analysis of human immunodeficiency virus type 1 (HIV-1) variants and levels of infection in dendritic and T cells from symptomatic HIV-1-infected patients. J Gen Virol. 1998;79:247-257.
20. Cameron PU, Forsum U, Teppler H, Steinman RM. During HIV-1 infection most blood dendritic cells are not productively infected and can induce allogeneic CD4+ T-cell clonal expansion. Clin Exp Immunol. 1992;88:226-236.
21. Sapp M, Engelmayer J, Larsson M, Granelli-Piperno A, Steinman R, Bhardwaj N. Dendritic cells generated from blood monocytes of HIV-1 patients are not infected and act as competent antigen presenting cells eliciting potent T-cell responses. Immunol Lett. 1999;66:121-128.
22. Blauvelt A, Clerici M, Lucey DR, et al. Functional studies of epidermal Langerhans cells and blood monocytes in HIV-infected persons. J Immunol. 1995;154:3506-3515.
23. Simmonds P, Balfe P, Peutherer JF, Ludlam CA, Bishop JO, Brown AJL. Human immunodeficiency virus-infected individuals contain provirus in small numbers of peripheral mononuclear cells and at low copy numbers. J Virol. 1990;64:864-872.
24. Benkirane M, Corbeau P, Housset V, Devaux C. An antibody that birids the immunoglobulin cdr3-like region of the CD4 molecule inhibits provirus transcription in HIV-infected T-cells. EMBO J. 1993;12:4909-4921.
25. Butler SL, Hansen MST, Bushman FD. A quantitative assay for HIV DNA integration in vivo. Nat Med. 2001;7:631-634.
26. Chun TW, Stuyver L, Mizell SB, et al. Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. Proc Nat Acad Sci U S A. 1997;94:13193-13197.
27. Wu YT, Marsh JW. Selective transcription and modulation of resting T cell activity by preintegrated HIV DNA. Science. 2001;293:1503-1506.
28. Schnittman SM, Psallidopoulos MC, Lane HC, et al. The reservoir for HIV-1 in human peripheral blood is a T-cell that maintains expression of CD4. Science. 1989;245:305-308.
29. Zhu TF, Muthui D, Holte S, et al. Evidence for human immunodeficiency virus type 1 replication in vivo in CD14(+) monocytes and its potential role as a source of virus in patients on highly active antiretroviral therapy. J Virol. 2002;76:707-716.
30. Chougnet C, Cohen SS, Kawamura T, et al. Normal immune function of monocyte-derived dendritic cells from HIV-infected individuals: implications for immunotherapy. J Immunol. 1999;163:1666-1673.
31. Patterson S, Rae A, Hockey N, Gilmour J, Gotch F. Plasmacytoid dendritic cells are highly susceptible to human immunodeficiency virus type 1 infection and release infectious virus. J Virol. 2001;75:6710-6713.
32. Chun TW, Carruth L, Finzi D, et al. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature. 1997;387:183-188.
33. Pope M, Betjes MGH, Romani N, et al. Conjugates of dendritic cells and memory T cells facilitate productive infection with HIV-1. Cell. 1994;78:389-398.
34. Clerici M, Shearer GM. AT(H)1->T(H)2 switch is a critical step in the etiology of HIV-infection. Immunol Today. 1993;14:107-110.
35. + blood dendritic cells are potent inducers of IFN-α in response to HIV-1 infection. J Immunol. 1994;152:4649-4662.
36. Stevenson M, Stanwick TL, Dempsey MP, Lamonica CA. HIV-1 replication is controlled at the level of T-cell activation and proviral integration. EMBO J. 1990;9:1551-1560.
37. Fugier-Vivier I, Servet-Delprat C, Rivailler P, Rissoan MC, Liu YJ, Rabourdin-Combe C. Measles virus suppresses cell-mediated immunity by interfering with the survival and functions of dendritic and T cells. J Exp Med. 1997;186:813-823.
38. Grosjean I, Caux C, Bella C, et al. Measles virus infects human dendritic cells and blocks their allostimulatory properties for CD4(+) T cells. J Exp Med. 1997;186:801-812.
39. + T cells in human immunodeficiency virus type 1-infected chimpanzees is associated with increased lymphocyte apoptosis. J Virol. 1998;72: 4623-4632.
40. Gougeon ML, Lecoeur H, Dulioust A, et al. Programmed cell death in peripheral lymphocytes from HIV-infected persons: increased susceptibility to apoptosis of CD4 and CD8 T cells correlates with lymphocyte activation and disease progression. J Immunol. 1996;156:3509-3520.
41. Badley AD, McEhinny JA, Leibson PJ, Lynch DH, Alderson MR, Paya CV. Upregulation of fas ligand by human immunodeficiency virus in human macrophages mediates apoptosis of uninfected T lymphocytes. J Virol. 1996;70:199-206.
42. Chen HC, Yip YK, George I, Tyorkin M, Salik E, Sperber K. Chronically HIV-1-infected monocytic cells induce apoptosis in cocultured T cells. J Immunol. 1998;161:4257-4267.